Effects of Electrical Stimulation on Osteoarthritis of the Knee
Not Applicable
Completed
- Conditions
- Osteoarthritis, Knee
- Interventions
- Device: InterX 5000
- Registration Number
- NCT00601497
- Lead Sponsor
- University of Virginia
- Brief Summary
The purpose of this study is to find out whether electrical stimulation can reduce knee pain and increase function in people with osteoarthritis of the knee.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 39
Inclusion Criteria
- 50 years of age or older
- Diagnosis of primary osteoarthritis of the knee (as defined by American College of Rheumatology criteria)
- Knee pain of at least six months duration
- Moderate or greater knee pain (defined as a score of 3 or greater on an 11 point numeric pain rating scale) for most days in the last month
- Willing to abide by protocol and treatment schedule.
Exclusion Criteria
- Implants, such as pacemaker, TENS, or insulin pump, incompatible with electrical stimulation
- Uncontrolled concomitant disease affecting the knee, such as: rheumatoid arthritis, systemic lupus erythema, psoriatic arthritis
- Pregnant or breast-feeding
- Intra-articular corticosteroid or hyaluronic acid injection into the knee within 3 months preceding study
- Arthroscopy of the knee within the past year
- Significant injury to the knee within the past 6 months
- Use of assistive devices other than a cane or knee brace
- Disease of spine or other lower extremity joints of sufficient degree to affect assessment of the knee
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 InterX 5000 - 2 InterX 5000 -
- Primary Outcome Measures
Name Time Method Knee Pain Baseline, Week 4, Week 8, and Week 12
- Secondary Outcome Measures
Name Time Method Knee function Baseline, Week 4, Week 8, and Week 12 Knee stiffness Baseline, Week 4, Week 8, and Week 12 Patient global assessment Baseline, Week 4, Week 8, and Week 12 Health-related quality of life Baseline, Week 4, Week 8, and Week 12
Trial Locations
- Locations (1)
University of Virginia
🇺🇸Charlottesville, Virginia, United States